Luhua Wang

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 14

Top Topics

Randomized Controlled Trial

Small Cell Lung Cancer

Top Venues

Thoracic cancer

Journal of oncology

BioMed research international

This page only lists publications with an associated author ORCID identifier.

Publications

Lei Deng, Gulidanna Shayan, Wei Jiang, Nan Bi, Luhua Wang
Phase III, multicenter, randomized trial of 45 Gy versus 30 Gy thoracic radiation for extensive-stage small cell lung cancer (ES-SCLC): Study protocol. Thoracic cancer 15 (11) (2024)
Lei Deng, Gulidanna Shayan, Wei Jiang, Nan Bi, Luhua Wang
Phase III, multicenter, randomized trial of 45 Gy versus 30 Gy thoracic radiation for extensive-stage small cell lung cancer (ES-SCLC): Study protocol. Thoracic cancer 15 (11) (2024)
Lei Deng, Gulidanna Shayan, Wei Jiang, Nan Bi, Luhua Wang
Phase III, multicenter, randomized trial of 45 Gy versus 30 Gy thoracic radiation for extensive-stage small cell lung cancer (ES-SCLC): Study protocol. Thoracic cancer (2024)
Lei Deng, Gulidanna Shayan, Wei Jiang, Nan Bi, Luhua Wang
Phase III, multicenter, randomized trial of 45 Gy versus 30 Gy thoracic radiation for extensive-stage small cell lung cancer (ES-SCLC): Study protocol. Thoracic cancer 15 (11) (2024)
Lei Deng, Gulidanna Shayan, Wei Jiang, Nan Bi, Luhua Wang
Phase III, multicenter, randomized trial of 45 Gy versus 30 Gy thoracic radiation for extensive-stage small cell lung cancer (ES-SCLC): Study protocol. Thoracic cancer 15 (11) (2024)
Lei Deng, Gulidanna Shayan, Wei Jiang, Nan Bi, Luhua Wang
Phase III, multicenter, randomized trial of 45 Gy versus 30 Gy thoracic radiation for extensive-stage small cell lung cancer (ES-SCLC): Study protocol. Thoracic cancer 15 (11) (2024)
Zeliang Ma, Bin Liang, Ran Wei, Yunsong Liu, Yongxing Bao, Meng Yuan, Yu Men, Jianyang Wang, Lei Deng, Yirui Zhai, Nan Bi, Luhua Wang, Jianrong Dai, Zhouguang Hui
Enhanced prediction of postoperative radiotherapy-induced esophagitis in non-small cell lung cancer: Dosiomic model development in a real-world cohort and validation in the PORT-C randomized controlled trial. Thoracic cancer (2023)
Linfang Wu, Yibo Gao, Daquan Wang, Yanhua Chen, Mingmin Qian, Xin Xu, Tao Zhang, Nan Bi, Luhua Wang
IDO1 Activity Predicts Lung Toxicity in Patients with Unresectable Stage III NSCLC and Chemoradiotherapy. Journal of oncology 2023 (2023)
Linfang Wu, Yibo Gao, Daquan Wang, Yanhua Chen, Mingmin Qian, Xin Xu, Tao Zhang, Nan Bi, Luhua Wang
IDO1 Activity Predicts Lung Toxicity in Patients with Unresectable Stage III NSCLC and Chemoradiotherapy. Journal of oncology 2023 (2023)
Linfang Wu, Shijun Zhao, Hui Huang, Wenqing Wang, Tao Zhang, Zongmei Zhou, Qin-Fu Feng, Jun Liang, Zefen Xiao, Zhouguang Hui, Jima Lv, Nan Bi, Luhua Wang
Treatment outcomes of patients with stage III non-small cell lung cancer and interstitial lung diseases receiving intensity-modulated radiation therapy: A single-center experience of 85 cases. Thoracic cancer 13 (11) (2022)
Xu Huang, Nan Bi, Jingbo Wang, Hua Ren, Desi Pan, Xian-Ping Lu, Luhua Wang
Chidamide and Radiotherapy Synergistically Induce Cell Apoptosis and Suppress Tumor Growth and Cancer Stemness by Regulating the MiR-375-EIF4G3 Axis in Lung Squamous Cell Carcinomas. Journal of oncology 2021 (2021)
Yufan Yang, Tao Zhang, Zongmei Zhou, Jun Liang, Dongfu Chen, Qin-Fu Feng, Zefen Xiao, Zhouguang Hui, Jima Lv, Lei Deng, Xin Wang, Wenqing Wang, Jianyang Wang, Wenyang Liu, Yirui Zhai, Jie Wang, Nan Bi, Luhua Wang
Development and validation of a prediction model using molecular marker for long-term survival in unresectable stage III non-small cell lung cancer treated with chemoradiotherapy. Thoracic cancer 13 (3) (2021)
Yongdong Zhuang, Yaoqin Xie, Luhua Wang, Shaomin Huang, Li-Xin Chen, Yuenan Wang
DVH Prediction for VMAT in NPC with GRU-RNN: An Improved Method by Considering Biological Effects. BioMed research international 2021 (2021)
Wei Jiang, Wenjue Zhang, Lihong Wu, Lipin Liu, Yu Men, Jingbo Wang, Jun Liang, Zhouguang Hui, Zongmei Zhou, Nan Bi, Luhua Wang
MicroRNA-Related Polymorphisms in PI3K/Akt/mTOR Pathway Genes Are Predictive of Limited-Disease Small Cell Lung Cancer Treatment Outcomes. BioMed research international 2017 (2017)